Jpmorgan Chase & Co »

Eterna Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Eterna Therapeutics (ERNA) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Eterna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eterna Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eterna Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $24 14 1.79
2023-09-30 $31 14 2.29
2023-06-30 $31 14 2.21
2023-03-31 $0 14 0.00
2022-12-31 $0 14 0.00